A study carried out by teams from the Institut Pasteur, the Institut Cochin (Inserm, CNRS, Paris Descartes University), and the Wellcome Trust Centre for Molecular Parasitology at the University of Glasgow, may very well redefine current approaches to malaria and toxoplasmosis research in terms of treatment development.
Rendez-vous du 17 au 19 octobre 2013 Place Carrée au Forum des Halles pour « Sciences au Carré(e) » Un événement grand public, gratuit et innovant proposé par les principaux organismes de recherche français pour éveiller la curiosité scientifique !
Certain parts of DNA are highly mobile and their dynamic motion participates in controlling gene expression. The research team working under Maria‐Elena Torres‐Padilla, an Inserm research director at the Institute of Genetics and Molecular and Cellular Biology, has just developed a method of observing the organisation and movements of the genome in time and space.
The impact of depression on a person contracting cancer has long been suspected, without any study having definitely confirmed or rejected this theory. The links have now been investigated by Cédric Lemogne, a member of the team headed by Marie Zins (INSERM’s Mixed Research Unit 1018 “Epidemiology and Population Health Research Centre”, AP-HP, University of Versailles Saint-Quentin), who monitored 14,203 people between 1994 and 2009, including 1119 who developed...
A team of researchers led by Michel De Waard, Inserm Research Director at the Grenoble Institute of Neurosciences (Inserm, University Joseph Fourier, CNRS), has discovered that an African medicinal plant produces large quantities of molecules with analgesic properties.
Inserm researcher Elvire Gouze, and her associates from the Mediterranean Centre for Molecular Medicine in Nice (Inserm Unit 106), have succeeded in restoring bone growth in mice suffering from this developmental pathology.
By means of virtual screening and experiments on mice and human cells in culture, the scientists were able to screen 200,000 compounds and selected two that allowed the causal mutated protein in cystic fibrosis to express itself and fulfill its function.
A l’occasion de la journée mondiale de la maladie d’Alzheimer qui se tiendra le 21 septembre 2013, le service de presse de l’Inserm vous compile les dernières actualités/avancées sur cette maladie.
The European Union commits funds to the FIBRO-TARGETS research consortium
Menée par le Pr Philippe Gabriel Steg, de l'hôpital Bichat, (AP-HP) et l’équipe de recherche affiliée au Département Hospitalo-Universitaire FIRE, à l’Université Paris-Diderot et à l'Unité Inserm U-698, l’étude a porté sur plus de 24 000 patients traités par angioplastie et sur un nouveau traitement antiplaquettaire injectable inhibant la formation des caillots de plaquettes, le cangrelor. Les chercheurs ont analysé la totalité des résultats obtenus avec ce nouveau traitement...